4
Changes in Ownership
Alkermes plc. Filed Acc 0001520262-26-000118
EVP R&D, Chief Medical Officer sold 9,000 shares at $46.99 ($422,874)
- EVP R&D, Chief Medical Officer acquired 5,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Hopkinson Craig C. · EVP R&D, Chief Medical Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-09-01 | Exercise or conversion : show line 1 in the form 10b5-1 | +5,000 | $24.59 | $122,950 | 74,389 | D |
| 2026-09-01 | Sale : show line 2 in the form 10b5-1 | −9,000 | $46.99 | $422,874 | 65,389 | D |
| Open-market sales · 9,000 sh · avg $46.99 · $422,874 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-09-01 | Exercise or conversion : show line 3 in the form 10b5-1 Employee Stock Option (Right to Buy) | −5,000 | 61,276 | D |
Loading xslF345X06/form4.xml…